HPS Pharmacies wish to give notice that Ferring Pharmaceuticals are currently experiencing an interruption to the supply of Minirin® Nasal Spray as follows:
Minirin® Nasal Spray
Desmopressin acetate 10mcg/spray
This supply interruption is due to a precautionary global recall of the product. Following testing of samples of Minirin® Nasal Spray supplied overseas, a low volume and of out-of-specification results for desmopressin content was observed in some vials. Ferring has initiated, in collaboration with the Therapeutic Goods Administration (TGA), a precautionary recall of potentially affected batches from the Australian market.
As there is currently no replacement batch available, consideration of the following alternative presentations of desmopressin may be required:
- Minirin® Tablets
- Minirin® Melt
- Minirin® Nasal Drops
The approved indications vary for these formulations; the product information should be consulted for appropriate use.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Ferring Pharmaceuticals on 1800 337 746 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates